Delivery Order SPE2DB22D2006-SPE2DB24FV9RC

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,970,697 units of Concerta ER 54 mg tablets. The contract has a ceiling value of $6,173.01 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $8,682.97 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of 4,564,312,353 units of CONCERTA ER 27 MG TABLET 100S, with an ultimate completion date of April 18, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,952.06 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Concerta ER 27mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
The Defense Logistics Agency (DLA) awarded a $11,921.03 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,561,153,231 units of Concerta ER 36 mg tablets. This firm-fixed-price contract has a completion date of June 2, 2023 and was not set aside for any specific business type. Amerisourcebergen is a major pharmaceutical distributor that has extensive Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice to provide a...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,016,943 units of Concerta ER 36 mg tablets. The $10,595.54 contract has an ultimate completion date of March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $15,214.04 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,610,451 units of the prescription medication Concerta ER 27 mg tablets, with a completion date of May 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $10,384.68, to Amerisourcebergen Drug Corp's Corporate Office division. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 2025, which enables the DLA to procure a wide range of pharmaceutical products and medical supplies for the Department of Defense (DoD) worldwide. The current delivery order is for 100 units of the CONCERTA ER 27 MG...
The U.S. Defense Logistics Agency (DLA) has awarded a $7,244.82 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Concerta ER 27 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $17,854.00 contract is for the supply of 100 units of the medication Concerta ER 36 MG Tablet. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This is a $14,185.08 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,564,959,479 units of Concerta ER 27 mg tablets. The contract has a period of performance through June 21, 2024 and is a firm-fixed price contract. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV9RC
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract worth $13,165.57 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,338,552 units of Concerta ER 27 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 22, 2024. This award was made on a full and open competition basis without any set-aside designation.

Generated 7/19/24, 9:52 AM